Ontology highlight
ABSTRACT: Significance
Immunosuppression is an almost universal hallmark of pancreatic cancer, although this tumor entity is highly heterogeneous across its different subtypes and phenotypes. Here, we provide evidence that the diverse TME of pancreatic cancer is a central executor of various different context-dependent modes of immunosuppression, and discuss key challenges and novel opportunities to uncover, functionalize, and target the central drivers and functional nodes of immunosuppression for therapeutic exploitation.
SUBMITTER: Falcomata C
PROVIDER: S-EPMC9900325 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
Falcomatà Chiara C Bärthel Stefanie S Schneider Günter G Rad Roland R Schmidt-Supprian Marc M Saur Dieter D
Cancer discovery 20230201 2
Immunotherapies have shown benefits across a range of human cancers, but not pancreatic ductal adenocarcinoma (PDAC). Recent evidence suggests that the immunosuppressive tumor microenvironment (TME) constitutes an important roadblock to their efficacy. The landscape of the TME differs substantially across PDAC subtypes, indicating context-specific principles of immunosuppression. In this review, we discuss how PDAC cells, the local TME, and systemic host and environmental factors drive immunosup ...[more]